Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation

被引:14
作者
Kiss, Nimrod B. [1 ,2 ]
Muth, Andreas [3 ]
Andreasson, Adam [1 ,2 ]
Juhlin, C. Christofer [2 ,4 ]
Geli, Janos [1 ]
Backdahl, Martin [1 ]
Hoog, Anders [4 ]
Wangberg, Bo [3 ]
Nilsson, Ola [5 ]
Ahlman, Hakan [3 ]
Larsson, Catharina [1 ,2 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Canc Ctr Karolinska, Stockholm, Sweden
[3] Sahlgrens Univ Hosp, Dept Surg, Gothenburg, Sweden
[4] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[5] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Molecular genetics; Gene regulation; Metastasis; Adrenal medulla; Endocrine therapy; MALIGNANT PHEOCHROMOCYTOMA; SPORADIC PHEOCHROMOCYTOMAS; SUCCINATE-DEHYDROGENASE; PROLYL HYDROXYLASE; GENE-MUTATIONS; METHYLATION; EXPRESSION; CANCER; CELLS; SDHB;
D O I
10.1530/ERC-12-0267
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrent alterations in promoter methylation of tumor suppressor genes (TSGs) and LINE1 (L1RE1) repeat elements were previously reported in pheochromocytoma and abdominal paraganglioma. This study was undertaken to explore CpG methylation abnormalities in an extended tumor panel and assess possible relationships between metastatic disease and mutation status. CpG methylation was quantified by bisulfite pyrosequencing for selected TSG promoters and LINE1 repeats. Methylation indices above normal reference were observed for DCR2 (TNFRSF10D), CDH1, P16 (CDKN2A), RARB, and RASSF1A. Z-scores for overall TSG, and individual TSG methylation levels, but not LINE1, were significantly correlated with metastatic disease, paraganglioma, disease predisposition, or outcome. Most strikingly, P16 hypermethylation was strongly associated with SDHB mutation as opposed to RET/MEN2, VHL/VHL, or NF1-related disease. Parallel analyses of constitutional, tumor, and metastasis DNA implicate an order of events where constitutional SDHB mutations are followed by TSG hypermethylation and 1p loss in primary tumors, later transferred to metastatic tissue. In the combined material, P16 hypermethylation was prevalent in SDHB-mutated samples and was associated with short disease-related survival. The findings verify the previously reported importance of P16 and other TSG hypermethylation in an independent tumor series. Furthermore, a constitutional SDHB mutation is proposed to predispose for an epigenetic tumor phenotype occurring before the emanation of clinically recognized malignancy.
引用
收藏
页码:65 / 78
页数:14
相关论文
共 39 条
[1]   The emerging functions of histone demethylases [J].
Agger, Karl ;
Christensen, Jesper ;
Cloos, Paul A. C. ;
Helin, Kristian .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (02) :159-168
[2]   Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma [J].
Baysal, BE ;
Ferrell, RE ;
Willett-Brozick, JE ;
Lawrence, EC ;
Myssiorek, D ;
Bosch, A ;
van der Mey, A ;
Taschner, PEM ;
Rubinstein, WS ;
Myers, EN ;
Richard, CW ;
Cornelisse, CJ ;
Devilee, P ;
Devlin, B .
SCIENCE, 2000, 287 (5454) :848-851
[3]   Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas [J].
Benn, DE ;
Croxson, MS ;
Tucker, K ;
Bambach, CP ;
Richardson, AL ;
Delbridge, L ;
Pullan, PT ;
Hammond, J ;
Marsh, DJ ;
Robinson, BG .
ONCOGENE, 2003, 22 (09) :1358-1364
[4]  
Boedeker C C, 2011, Laryngorhinootologie, V90 Suppl 1, pS56, DOI 10.1055/s-0030-1270447
[5]   SDHA is a tumor suppressor gene causing paraganglioma [J].
Burnichon, Nelly ;
Briere, Jean-Jacques ;
Libe, Rossella ;
Vescovo, Laure ;
Riviere, Julie ;
Tissier, Frederique ;
Jouanno, Elodie ;
Jeunemaitre, Xavier ;
Benit, Paule ;
Tzagoloff, Alexander ;
Rustin, Pierre ;
Bertherat, Jerome ;
Favier, Judith ;
Gimenez-Roqueplo, Anne-Paule .
HUMAN MOLECULAR GENETICS, 2010, 19 (15) :3011-3020
[6]   Genetic and epigenetic profile of sporadic pheochromocytomas [J].
Cascon, A ;
Ruiz-Llorente, S ;
Fraga, MF ;
Leton, R ;
Telleria, D ;
Sastre, J ;
Diez, JJ ;
Diaz-Guerra, GM ;
Perez, JAD ;
Benitez, J ;
Esteller, M ;
Robledo, M .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (03) :e30
[7]   Genetic mutation screening in an Italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients [J].
Castellano, M. ;
Mori, L. ;
Giacche, M. ;
Agliozzo, E. ;
Tosini, R. ;
Panarotto, A. ;
Cappelli, C. ;
Mulatero, P. ;
Cumetti, D. ;
Veglio, E. ;
Agabiti-Rosei, E. .
PHEOCHROMOCYTOMA, 2006, 1073 :156-165
[8]   Cells silenced for SDHB expression display characteristic features of the tumor phenotype [J].
Cervera, Ana M. ;
Apostolova, Nadezda ;
Luna Crespo, Francisco ;
Mata, Manuel ;
McCreath, Kenneth J. .
CANCER RESEARCH, 2008, 68 (11) :4058-4067
[9]   Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells [J].
Cervera, Ana M. ;
Bayley, Jean-Pierre ;
Devilee, Peter ;
McCreath, Kenneth J. .
MOLECULAR CANCER, 2009, 8 :89
[10]   Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma [J].
Comino-Mendez, Inaki ;
Gracia-Aznarez, Francisco J. ;
Schiavi, Francesca ;
Landa, Inigo ;
Leandro-Garcia, Luis J. ;
Leton, Roco ;
Honrado, Emiliano ;
Ramos-Medina, Rocio ;
Caronia, Daniela ;
Pita, Guillermo ;
Gomez-Grana, Alvaro ;
de Cubas, Aguirre A. ;
Inglada-Perez, Lucia ;
Maliszewska, Agnieszka ;
Taschin, Elisa ;
Bobisse, Sara ;
Pica, Giuseppe ;
Loli, Paola ;
Hernandez-Lavado, Rafael ;
Diaz, Jose A. ;
Gomez-Morales, Mercedes ;
Gonzalez-Neira, Anna ;
Roncador, Giovanna ;
Rodriguez-Antona, Cristina ;
Benitez, Javier ;
Mannelli, Massimo ;
Opocher, Giuseppe ;
Robledo, Mercedes ;
Cascon, Alberto .
NATURE GENETICS, 2011, 43 (07) :663-U189